Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.

Transplantation proceedings - 1 Mar 2005

Joh J W, Lee H H, Park J W, Lee D H, Yoo B C, Lee K W, Kim S J

Abstract excerpt

Renal recipients with hepatitis B virus (HBV) should be treated with prolonged lamivudine. However, lamivudine resistance usually results after YMDD mutation within the HBV polymerase gene. Thereupon, the aim of this study was to investigate the genotypic resistance to lamivudine among renal tran...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Primers
Share to DNA, Viral
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B

Share to Hepatitis B e Antigens

Share to Hepatitis B virus

Share to Kidney Transplantation

Share to Lamivudine

Source

Identifiers

PMID: 15848680
DOI: 10.1016/j.transproceed.2004.11.037

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15848680-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients.PMID 15848680Read ↗

The incidence and clinical outcome of YMDD mutants in hepatitis B surface antigen-positive renal allograft recipients after prolonged lamivudine therapy.Semantic proximity Read ↗

Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine.Semantic proximity Read ↗

Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.Semantic proximity Read ↗

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.Semantic proximity Read ↗

Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivoSemantic proximity Read ↗

[Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].Semantic proximity Read ↗

Evolution of wild type and mutants of the YMDD motif of hepatitis B virus polymerase during lamivudine therapy.Semantic proximity Read ↗

Rate of YMDD motif mutants in lamivudine-untreated Iranian patients with chronic hepatitis B virus infection.Semantic proximity Read ↗

The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment.Semantic proximity Read ↗

Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.Semantic proximity Read ↗

HBV GENOTYPIC RESISTANCE TO LAMIVUDINE IN KIDNEY RECIPIENTS AND HEMODIALYZED PATIENTSSemantic proximity Read ↗

Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.